Ann: Quarterly Update and Appendix 4C, page-31

Hi Chilunsin

Agree with all you say and like i have said previously under normal circumstances ref takeover you would be on the money

However the way this trial is going to pan out from here and now

Its a case of all or nothing for the big Pharmas

because post trial if successful were going to market, when under normal circumstances we would be looking for multi million dollars to fund a PH3 before going to market at which time a pharma would step in to take the trials forwards


Personally i would like them to split the rights as Sarepta did

We take it through Europe and the pharma take it through the FDA

But they would have to, for mine be speaking the numbers that Roche paid up placebo or no placebo cash or no cash at bank, that is now a bench mark and carries a failure taboot

and their lies the the conundrum if they are talking those types of figures they will just take the farm not acreage

The alternative is we raise big time and dont worry about dilution and go it alone because if the trial is a success it wont matter

see how we go